Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'carmoxirole hydrochloride'

Search results for: 'carmoxirole hydrochloride'

Items 21-30 of 58

Page
per page
  1. MPEP Hydrochloride
    A3633 MPEP Hydrochloride
    Target: Glutamate (Metabotropic) Group I Receptors
    Summary: MGlu5 receptor antagonist
      Soluble in DMSO
  2. GNE-617 hydrochloride
    B1309 GNE-617 hydrochloride
    Target: Nampt
    Summary: NAMPT inhibitor, potent and competitive
      Soluble in DMSO
  3. R 568 hydrochloride
    B7504 R 568 hydrochloride
    Target: Calcium-Sensing Receptors (CaSRs)
    Summary: Positive allosteric modulator of the human calcium-sensing receptor (hCaSR)
      Soluble in DMSO
  4. RP 001 hydrochloride
    B7634 RP 001 hydrochloride
    Target: S1P receptors
    Summary: S1P1 receptor agonist
      <43.25 mg/mL
  5. W-7 hydrochloride
    B6278 W-7 hydrochloride
    Target: Calmodulins
    Summary: calmodulin antagonist
      Soluble in DMSO
  6. BW 723C86 hydrochloride
    B6574 BW 723C86 hydrochloride
    Target: 5-HT2 Receptors
    Summary: 5-HT2B agonist
      Soluble in DMSO
  7. PD153035 hydrochloride
    A8199 PD153035 hydrochloride
     1 Citation
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥3.97 mg/mL
  8. Etifoxine hydrochloride
    A3401 Etifoxine hydrochloride
    Target: GABAA receptor
    Summary: GABAA receptor potentiator
      ≥33.7 mg/mL
  9. KN-93 hydrochloride
    B1306 KN-93 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaMK II inhibitor
      ≥26.9 mg/mL
  10. Pitolisant hydrochloride
    A3727 Pitolisant hydrochloride
    Summary: Nonimidazole inverse agonist
      ≥16.6 mg/mL

Items 21-30 of 58

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 53item
  2. Natural Products 2item
  3. Lab Reagents 2item
Specificity
  1. Selective 31item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 1 item
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. mTOR 1 item
  9. Thymidine Phosphorylases 1 item
  10. VEGFR 1 item
  11. PDGFR 1 item
  12. c-Kit 1 item
  13. Phosphodiesterases (PDEs) 1 item
  14. Sir2-like Family Deacetylases (Sirtuins) 1 item
  15. Aminopeptidases 1 item
  16. EGFR 2item
  17. FAK 1 item
  18. Syk 1 item
  19. DNA-PK 1 item
  20. HSP90 1 item
  21. AMPK 1 item
  22. Topoisomerases 1 item
  23. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  24. Pyk2 1 item
  25. 5-HT2 Receptors 2item
  26. S1P receptors 1 item
  27. ALK 1 item
  28. Myosin light chain kinases (MLCKs) 1 item
  29. 5-HT3 Receptors 2item
  30. Squalene epoxidases 2item
  31. Nampt 1 item
  32. Glutamate (Metabotropic) Group I Receptors 1 item
  33. Histamine H1 Receptors 1 item
  34. Sigma Receptors 1 item
  35. AChE 1 item
  36. Inward Rectifier Potassium (Kir) Channels 1 item
  37. c-RET 1 item
  38. guanylyl cyclase 1 item
  39. dopamine receptor 1 item
  40. 5-HT1 Receptor 2item
  41. 5-HT2 Receptor 1 item
  42. NMPRTase 1 item
  43. IKK 1 item
  44. Antibiotic 1 item
  45. Calmodulins 1 item
  46. Calcium-Sensing Receptors (CaSRs) 2item
  47. PAR receptor 1 item
  48. TRPC channel 1 item
  49. GABAA receptor 1 item
  50. CRF1 Receptors 1 item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 2item
  4. Breast Cancer 3item
  5. Cancer 18item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 2item
  8. Colorectal Cancer 2item
  9. Erectile Dysfunction 1 item
  10. Glioblastoma 2item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Lung Cancer 2item
  15. Multidrug Resistance Studies 1 item
  16. Multiple Myeloma 2item
  17. Narcolepsy 1 item
  18. Non-small Cell Lung Cancer 1 item
  19. Pancreatic Cancer 2item
  20. Prostate Cancer 3item
  21. Schizophrenia 1 item
  22. Type 2 Diabetes 1 item